University of Washington at SITC 2026
Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website
University of Washington brings 4 presentations to SITC 2026 in Phoenix. Its program centres on the side effects and quality of life of patients treated with checkpoint inhibitors, along with T-cell responses in tumors and to vaccines. One concrete aim is predicting which patients will develop inflammatory arthritis while receiving immunotherapy.
| Organization | SITC 2026 Attendance |
|---|---|
University of Washington Seattle, WA | |
A public research university. | Poster Fri Nov 6 12:15–1:45pm 5:30–7pm Poster Sat Nov 7 12:30–1:30pm 6:40–8:10pm Poster Sat Nov 7 12:30–1:30pm 6:40–8:10pm Poster Sat Nov 7 12:30–1:30pm 6:40–8:10pm |
Instantly find 20 buyers from University of Washington
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction